Donor cell leukemia after umbilical cord blood transplantation: recurrent or de novo? The importance of diagnosis for therapeutic decision making

Int J Hematol. 2011 Apr;93(4):563-565. doi: 10.1007/s12185-011-0814-y. Epub 2011 Apr 9.

Authors

Yusuke Shono¹, Mizuha Kosugi-Kanaya², Souichi Shiratori², Junichi Sugita², Katsuya Fujimoto², Takeshi Kondo², Mitsufumi Nishio², Junji Tanaka², Masahiro Imamura²

Affiliations

¹ Stem Cell Transplantation Center, Hokkaido University Hospital, Kita-17, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan. [email protected].
² Stem Cell Transplantation Center, Hokkaido University Hospital, Kita-17, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan.

PMID: 21479587
DOI: 10.1007/s12185-011-0814-y

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Cord Blood Stem Cell Transplantation / adverse effects*
Female
Humans
Neoplasm Recurrence, Local / diagnosis*
Neoplasm Recurrence, Local / etiology
Neoplasm Recurrence, Local / therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / etiology
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy